Aster Capital Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-811
Closed -$28.6K – 1092
2025
Q3
$28.6K Buy
811
+538
+197% +$18.5K 0.01% 612
2025
Q2
$8.95K Sell
273
-10,975
-98% -$357K ﹤0.01% 811
2025
Q1
$436K Buy
11,248
+10,857
+2,777% +$403K 0.08% 318
2024
Q4
$11.9K Buy
+391
New +$12.6K ﹤0.01% 732

Other funds holding ATRC

Aster Capital Management's ATRC Position: Q4 2025 in Review

Aster Capital Management sold out of AtriCure (ATRC) in Q4 2025, closing a stake of 811 shares — an estimated $28.6K sold.

Aster Capital Management first reported a position in ATRC in Q4 2024 and held it in 4 quarters. The position peaked at $436K in Q1 2025. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2025.

  • Aster Capital Management reported no remaining AtriCure position as of Q4 2025 after selling out during the quarter.
  • Aster Capital Management sold 811 AtriCure shares in Q4 2025, an estimated $28.6K.
  • Aster Capital Management first reported a position in AtriCure in Q4 2024 and held it in 4 quarters.
  • Aster Capital Management's AtriCure position peaked at $436K in Q1 2025.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2025.

Based on Aster Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.